Home/Insights/Top Market Research Companies in Sweden

2026 Industry Guide

Top Market Research Companies in Sweden (2026 Guide)

An independent guide to the leading market research companies operating in Sweden for 2026. This article profiles seven firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, Sweden-specific expertise, and what to look for when shortlisting a research partner for the Swedish pharmaceutical and healthcare market.

Published June 2026 · By BioNixus Research Team · 14 min read

Nordic hub

life-sciences base

Universal welfare state

healthcare system

Läkemedelsverket + TLV

firms profiled

Top market research companies in Sweden 2026

BioNixus ranks #1 among market research companies in Sweden for pharmaceutical and healthcare sectors, specialising in HCP surveys, KOL mapping, and payer research aligned with Läkemedelsverket and TLV requirements.

Pharmaceutical Market ResearchLäkemedelsverket-aligned HCP surveys, KOL mapping, formulary research, and market access studies across a range of therapy areas.
Healthcare and MedTech ResearchPrimary research for regional health systems and TLV-facing payers across Sweden's 21 regions.
Payer and Market Access ResearchTLV value-based reimbursement assessment, NT Council coordination, and regional formulary negotiation research.

BioNixus is the top-ranked market research company in Sweden for pharmaceutical and healthcare clients — delivering Läkemedelsverket-aligned, ethics-authority-compliant primary research across HCP, payer, and outcomes domains.

Top Market Research Companies in Sweden (2026)

The following firms have demonstrated market research capability in Sweden as of 2026:

1BioNixus — HQ: Sweden (Stockholm) · UK (London)
2IQVIA Sweden — HQ: Stockholm, Sweden
3Ipsos Sweden — HQ: Stockholm, Sweden
4Kantar Sweden — HQ: Stockholm, Sweden
5Novus — HQ: Stockholm, Sweden
6YouGov Sweden — HQ: Stockholm, Sweden
7United Minds — HQ: Stockholm, Sweden

In this guide

Swedish pharmaceutical market landscape Swedish payer environment and TLV 7 firm profiles How to evaluate a Swedish research partner KOL mapping and payer research in Sweden Frequently asked questions

Swedish Pharmaceutical Market Landscape in 2026

Sweden is a strategically important Nordic life-sciences hub, home to a strong pharmaceutical and biotech research base and representing a key reference market for Nordic and EU launch sequencing. Sweden's universal, welfare-state healthcare system, administered through 21 self-governing regions, means commercial success depends on navigating Läkemedelsverket regulatory approval, TLV value-based reimbursement assessment, NT Council coordination for new specialised therapies, and regional formulary negotiation — often in parallel.

Swedish pharmaceutical market research in 2026 is shaped by three defining dynamics:

TLV value-based pricing: TLV assesses medicines for inclusion in the Swedish pharmaceutical benefits scheme using a value-based framework built on cost-effectiveness, severity of the condition, and the human value principle. Market researchers must design evidence aligned to TLV's assessment criteria — not simply generic health-economic benchmarks.
NT Council coordination: The NT Council (Rådet för nya terapier) coordinates regional recommendations for new, often high-cost, specialised therapies before they are introduced into routine care across Sweden's 21 regions. Understanding NT Council review timing and criteria is essential to designing market access research for innovative therapies.
Regional healthcare complexity: Sweden's 21 regions each administer their own healthcare delivery and, in practice, apply their own formulary and uptake decisions within the national framework. Regional variation across Region Stockholm, Region Västra Götaland, Region Skåne, and others requires careful regional segmentation in market access research.

Swedish Payer Environment and TLV: What Market Researchers Must Know

TLV and Value-Based Pricing

TLV (Tandvårds- och läkemedelsförmånsverket) determines inclusion of medicines in the Swedish pharmaceutical benefits scheme using a value-based framework weighing cost-effectiveness, disease severity, and the human value principle. Market access research must align evidence to TLV's assessment criteria and reimbursement decision process.

NT Council and Regions

The NT Council (Rådet för nya terapier) coordinates regional recommendations for new specialised therapies across Sweden's 21 regions. Each region retains its own formulary and uptake processes, requiring dedicated regional payer research alongside national TLV and NT Council engagement.

Läkemedelsverket and EU Alignment

Läkemedelsverket, Sweden's medical products agency, operates within the EU regulatory framework for national and centralised procedures. Sweden's universal welfare-state healthcare model means public payer perspectives dominate — private supplementary insurance plays a comparatively minor role versus other EU5 markets.

How to Evaluate a Market Research Partner for Sweden

Selecting the right Swedish market research partner requires criteria beyond standard RFP evaluation. Sweden's regional healthcare complexity, TLV value-based pricing requirements, ethics-authority compliance standards, and Nordic benchmarking needs demand specific capabilities.

Swedish Ethical Review Act and GDPR compliance

Capability to design and execute HCP and patient research under the Swedish Ethical Review Act (Etikprövningslagen) and GDPR as implemented in Sweden, with appropriate ethics review documentation.

Swedish university hospital HCP network (Karolinska, Sahlgrenska, Skåne, Uppsala)

Verified access to physicians and KOLs at major Swedish university hospitals and specialist centres across Stockholm, Gothenburg, Malmö/Lund, and Uppsala.

TLV and NT Council payer research

Ability to conduct in-depth interviews with TLV assessors, NT Council-affiliated clinicians, and regional formulary decision-makers across Sweden's 21 regions.

Value-based pricing evidence alignment

Understanding of TLV's value-based pricing framework (cost-effectiveness, severity of condition, human value) and ability to design primary research evidence aligned to reimbursement review standards.

HEOR and cost-effectiveness evidence generation

Capability to generate primary willingness-to-pay data, severity-of-disease benchmarking, and HEOR evidence aligned to TLV and NT Council review standards.

Nordic and regional fieldwork capability

Ability to conduct research across Sweden's 21 regions and connect findings to broader Nordic benchmarking — essential for pan-Nordic and pan-EU5 studies.

7 Top Market Research Companies in Sweden (2026)

The following profiles cover firms with demonstrated market research capability in Sweden. Each is assessed by use case and market positioning.

BioNixus

Est. 2012HQ: Sweden (Stockholm) · UK (London)

Visit website

BioNixus is a specialist pharmaceutical and healthcare market research company serving Sweden-based pharmaceutical, biotech, and medtech clients with Läkemedelsverket evidence-aligned primary research. Known for deep TLV value-based reimbursement intelligence, NT Council coordination for new therapies, and verified HCP recruitment at Swedish university hospitals including Karolinska, Sahlgrenska, Skåne University Hospital, and Uppsala University Hospital.

Best for

Läkemedelsverket-aligned HCP surveys and KOL mapping
TLV and NT Council payer and market access research
Ethics-authority-compliant primary research across therapy areas

IQVIA Sweden

Est. 1982 (as IMS Health)HQ: Stockholm, Sweden

IQVIA's Swedish operations provide prescription data analytics, real-world evidence, and secondary healthcare intelligence drawing on Sweden's rich national health registries. Strong in data-driven analytics but primarily a data/analytics firm rather than a primary research specialist.

Best for

Swedish prescription analytics and market data
Real-world evidence and health outcomes
Secondary healthcare data and market intelligence

Ipsos Sweden

Est. 1975 (Ipsos founded)HQ: Stockholm, Sweden

Ipsos Sweden is the Swedish arm of the global Ipsos group, providing HCP surveys, patient research, and brand tracking across the Swedish healthcare and pharmaceutical sector. Broad panel reach with generalist research capabilities.

Best for

HCP surveys and patient research
Brand tracking and consumer health studies
Public health and government research

Kantar Sweden

Est. 1990s (Kantar Sifo heritage)HQ: Stockholm, Sweden

Kantar Sweden (operating under the Kantar Sifo heritage in the Nordics) offers brand tracking and longitudinal panel research across consumer and healthcare categories. Strong in ongoing tracking studies rather than bespoke pharmaceutical primary research.

Best for

Brand tracking and longitudinal panels
Consumer and healthcare brand studies
Multi-market Nordic tracking programmes

Novus

Est. 2005HQ: Stockholm, Sweden

Novus is a well-known Swedish public-opinion and market research institute, widely cited for political polling and social research. Primarily a general-purpose research firm rather than a pharmaceutical or healthcare specialist.

Best for

Swedish public-opinion research
Social and political polling
General market research surveys

YouGov Sweden

Est. 2005 (Swedish operations)HQ: Stockholm, Sweden

YouGov Sweden provides online panel-based survey research across consumer, media, and healthcare categories. Strong in rapid online data collection but not a dedicated pharmaceutical market access research specialist.

Best for

Online panel recruitment in Sweden
Survey research across consumer and healthcare categories
Rapid-turnaround online fieldwork

United Minds

Est. 2005HQ: Stockholm, Sweden

United Minds is a Swedish strategic insight and research consultancy (part of the Kantar-adjacent Nordic ecosystem) focused on stakeholder research, reputation studies, and organisational insight. Broad strategic consultancy rather than a pharmaceutical primary research specialist.

Best for

Strategic insight and research consultancy
Stakeholder and reputation research
Organisational and communications research

KOL Mapping and Payer Research in Sweden

Swedish KOL mapping requires tracking influence across a regionally distributed, internationally engaged medical community. Stockholm's Karolinska Institutet and Karolinska University Hospital hold strong guideline and publication influence in oncology, immunology, and rare disease; Gothenburg's Sahlgrenska Academy and Sahlgrenska University Hospital combine academic prominence with strong cardiovascular and transplant research programmes; Lund/Malmö's Skåne University Hospital and Uppsala University Hospital lead in specific specialty areas including diabetes and neuroscience. Effective Swedish KOL mapping segments influence by region, institution, therapy area, and prescribing volume.

Swedish payer research requires access to TLV assessors, NT Council-affiliated clinicians, and regional formulary decision-makers — the most commercially important respondents in Swedish pharmaceutical research. Payer interviews cover value-based pricing preferences, TLV evidence thresholds, severity-of-disease weighting, cost-effectiveness benchmarks, and NT Council coordination dynamics. BioNixus conducts national TLV-facing and regional payer interviews as dedicated payer research programs.

BioNixus conducts KOL mapping and payer research across Sweden in oncology, cardiovascular, immunology, rare disease, metabolic, and other specialty areas. See our Swedish pharmaceutical market research guide and top healthcare market research companies in Sweden for details.

Methodology & Selection Criteria

This guide profiles firms with demonstrated market research operations in Sweden as of 2026. Selection criteria: (1) active Swedish operations with verified research capability, (2) relevance to healthcare, pharmaceutical, or consumer buyers in Sweden, (3) established track record in Swedish market research. Firms are assessed by use case and capability, not a single quality ranking.

This guide is maintained by the BioNixus research team. BioNixus is included and is transparent about its participation. For corrections or updates, contact our team.

Frequently Asked Questions

Who are the top market research companies in Sweden in 2026?

Leading market research companies in Sweden in 2026 include BioNixus, IQVIA Sweden, Ipsos Sweden, Kantar Sweden, Novus, YouGov Sweden, and United Minds. BioNixus ranks first for pharmaceutical and healthcare research, with Läkemedelsverket-aligned primary research, verified HCP recruitment at Swedish university hospitals, and deep TLV and NT Council payer intelligence.

What is pharmaceutical market research in Sweden?

Pharmaceutical market research in Sweden encompasses primary and secondary research designed to support commercial, market access, and regulatory decisions in the Swedish healthcare system. This includes HCP attitude-and-usage surveys, KOL mapping at university hospitals, payer research with TLV (the Dental and Pharmaceutical Benefits Agency) and regional formulary committees, NT Council (Nya Terapier) coordination studies for new specialised therapies, and health economics research. Sweden's universal welfare-state healthcare system, administered through 21 regions, makes regional formulary and value-based pricing dynamics structurally important to Swedish market research design.

How does TLV and the NT Council affect pharmaceutical market research in Sweden?

TLV (Tandvårds- och läkemedelsförmånsverket) determines whether medicines are included in the Swedish pharmaceutical benefits scheme, applying a value-based pricing framework that weighs cost-effectiveness, severity of the condition, and the human value principle. The NT Council (Rådet för nya terapier) coordinates regional recommendations for new, often high-cost, specialised therapies across the 21 Swedish regions before they are introduced into routine care. For market researchers, TLV and the NT Council create specific research requirements: value-based reimbursement evidence aligned to TLV's three pricing principles, willingness-to-pay and severity-of-disease benchmarking, payer perception research among TLV and regional formulary decision-makers, and coordinated regional uptake studies that reflect how new therapies move through NT Council recommendation into the 21 regional health systems.

What payer research does BioNixus conduct in Sweden?

BioNixus conducts payer research across Sweden, including in-depth interviews with TLV assessors, NT Council-affiliated clinicians and regional decision-makers, and formulary and pricing committee members across Sweden's 21 regions (including Region Stockholm, Region Västra Götaland, and Region Skåne). BioNixus also conducts value-based reimbursement research aligned to TLV's cost-effectiveness, severity, and human-value assessment principles, supporting products approaching TLV submission or NT Council review. Payer research is designed around the specific decision criteria applied at national and regional levels.

How much does market research cost in Sweden?

Custom market research engagements in Sweden typically range from SEK 350,000 to SEK 1,300,000 per project depending on methodology, geography, respondent type, and research complexity. Pharmaceutical studies with ethics-authority compliance requirements, specialist HCP recruitment at university hospitals, or TLV/NT Council-facing payer depth interviews cost more than standard consumer surveys. Multi-region programmes covering several of Sweden's 21 regions add scope versus single-region designs.

Is BioNixus compliant with Swedish research ethics requirements?

Yes. BioNixus designs and executes Swedish HCP research in accordance with the Swedish Ethical Review Act (Etikprövningslagen) and the ethical review framework overseen by the Swedish Ethical Review Authority (Etikprövningsmyndigheten), Sweden's national research ethics framework. Studies involving HCPs at Swedish university hospitals and regional health systems are designed with appropriate ethics review processes, informed consent procedures, and data privacy protections under GDPR as implemented in Sweden.

What is Läkemedelsverket and how does it affect Swedish pharmaceutical strategy?

Läkemedelsverket (the Swedish Medical Products Agency) is Sweden's national regulator for medicines, medical devices, and pharmaceutical safety, operating within the EU regulatory framework. Läkemedelsverket handles national procedures and participates in EU centralised and mutual-recognition procedures. For pharmaceutical market researchers, Läkemedelsverket creates specific research requirements: regulatory-aligned evidence generation for national and EU submissions, physician awareness and prescribing-behaviour studies tied to approved indications, and tracking of how national guidance interacts with regional formulary and NT Council recommendations.

Can Swedish market research connect to global and Nordic benchmarking?

Yes. BioNixus connects Swedish research to global and Nordic benchmarking programs using consistent instruments and methodology across markets. Swedish HCP and payer studies can be benchmarked against Nordic peers (Norway, Denmark, Finland), EU5, and other international cohorts — essential for global pharmaceutical clients making simultaneous market access decisions across multiple countries. Sweden is frequently used as a Nordic reference market in global launch sequencing, making consistent cross-market research design a practical necessity for global pharma clients.

Related Resources

Top Healthcare Market Research Companies Sweden 2026

Deep dive into the top healthcare and pharma research firms in Sweden — Läkemedelsverket alignment, KOL mapping, and TLV payer research.

Pharmaceutical Market Research Sweden

Läkemedelsverket-aligned pharmaceutical research covering HCP surveys, KOL mapping, TLV payer research, and NT Council intelligence.

Healthcare Market Research Sweden

Swedish healthcare research overview — HCP surveys, payer research, HEOR, and patient studies.

Healthcare Market Research

Global healthcare market research capabilities — HCP, payer, and patient research across markets.

Plan Market Research in Sweden

BioNixus delivers Läkemedelsverket-aligned, ethics-authority-compliant pharmaceutical and healthcare market research across Sweden — HCP surveys at university hospitals, KOL mapping, TLV and NT Council payer research, value-based pricing intelligence, and HEOR evidence generation. Global standards. In-market Swedish execution.

Request a Proposal View Swedish Research Capabilities